Share it on:
Company Overview
HICKS is a household name in India, known for its thermometers for 100 years. The company was founded by Late Shri V P Gupta in 1962 with British collaboration and is an ISO 9001:2008 certified company. Today, HICKS boasts a diversified portfolio of 50 medical instruments, including medical disposables, consumables, diagnostics, and pharmaceutical products.
Product Portfolio:
- Thermometers: Various types for medical use.
- Monitoring Devices: Electronic BP Meter, Digital Weighing Scale, Fingertip Oximeter, Stethoscope.
- Rehabilitation Products: Lumbo Sacral Belt, Cervical Collar, Pouch Arm, Knee-Cap, Abdominal Belt.
- Home Health Products: Hot Water Bottle, Hot Water Bags, Ice Bag, Nebulizer, Pregnancy Test Card, Breast Pump, Adult Diaper.
- Medical Supplies: Plaster of Paris, Face Mask, Disposable Surgical Blade, Surgeon Cap.
Product Distribution:
- Sold through 3000 dealers across India.
- Supported by a dedicated sales team.
Infrastructure:
- Manufacturing unit in Aligarh, U.P., covering 7000 square yards with high-end facilities.
Distribution Network:
- 1500+ distributors across India.
- Offices in Delhi, Kolkata, Patna, Jaipur, Nagpur, Mumbai, Guwahati, and Chennai.
Clientele:
- Serves notable clients like Apollo Hospitals, Escort Hospital, Cadila Pharmaceutical, Ranbaxy Laboratories, Dr. Reddy’s Laboratories, and Glaxo.
Fundamentals
| Parameter | Value | Parameter | Value |
|---|---|---|---|
| Current Price | ₹ 1800 | Face Value | 10 |
| Debt to Equity | NA | Book Value | 1010 |
| Market Cap (in Cr.) | ₹ 40 | ROE (%) | 7.12 |
| P/B | 1.25 | P/E Ratio | 18.89 |
| PAN Number | AAACH9203R | EPS | 71.88 |
| ISIN | INE923S01017 | No. Of Shares (in Cr.) | 0.32 |
Promoters & Managements
| Hari Prakash Gupta | MD |
| Siddharth Gupta | Joint MD |
| Jai Narayan Tiwari | CFO |
Profit & Loss Statement
| P&L Statement | 2022 | 2023 |
|---|---|---|
| Revenue | 91.1 | 45.8 |
| Cost of Material Consumed | 41 | 22 |
| Gross Margins | 54.95 | 51.11 |
| Change in Inventory | 3 | 2 |
| Employee Benefit Expenses | 6 | 5 |
| Other Expenses | 31 | 13 |
| EBITDA | 10 | 3 |
| OPM | 10.99 | 6.67 |
| Other Income | 0.1 | 0.8 |
| Finance Cost | 0 | 0.4 |
| D&A | 0 | 0.3 |
| EBIT | 10 | 2.7 |
| EBIT Margins | 10.99 | 6 |
| PBT | 10 | 3 |
| PBT Margins | 10.99 | 6.67 |
| Tax | 2 | 0.7 |
| PAT | 8 | 2.3 |
| NPM | 8.79 | 5.11 |
| EPS | 266.67 | 71.88 |
Financial Ratios
| Financial Ratios | 2022 | 2023 |
|---|---|---|
| Operating Profit Margin (%) | 10.99 | 6.67 |
| Net Profit Margin (%) | 8.79 | 5.11 |
| Earnings Per Share (Diluted) | 266.67 | 71.88 |
Assets
| Assets | 2022 | 2023 |
|---|---|---|
| Fixed Assets | 2 | 2.6 |
| CWIP | 0 | 0 |
| Investments | 1 | 2.4 |
| Trade Receivables | 7 | 7 |
| Inventory | 12 | 9 |
| Other Assets | 19 | 19 |
| Total Assets | 41 | 40 |
Liabilities
| Liabilities | 2022 | 2023 |
|---|---|---|
| Share Capital | 0.3 | 0.32 |
| Face Value (FV) | 10 | 10 |
| Reserves | 29 | 32 |
| Borrowings | 4 | 4.5 |
| Trade Payables | 6 | 2.5 |
| Other Liabilities | 1.7 | 0.68 |
| Total Liabilities | 41 | 40 |
Cash Flow Statement
| Cash Flow Statement | 2022 | 2023 |
|---|---|---|
| PBT | 10 | 3 |
| OPBWC | 10 | 3.25 |
| Change in Receivables | -0.6 | -0.34 |
| Change in Inventories | 2 | 2.6 |
| Change in Payables | 0.7 | -3.91 |
| Other Changes | -1 | 2 |
| Working Capital Change | 1.1 | 0.35 |
| Cash Generated From Operations | 11.1 | 3.6 |
| Tax | 0 | 0 |
| Cash Flow From Operations | 11.1 | 3.6 |
| Purchase of PPE | -0.9 | -0.68 |
| Sale of PPE | 0 | 0 |
| Cash Flow From Investment | -1.7 | -0.87 |
| Borrowing | -0.2 | 0.41 |
| Dividend | 0 | 0 |
| Equity | 0 | 0 |
| Others From Financing | -3.4 | -1.55 |
| Cash Flow from Financing | -3.6 | -1.14 |
| Net Cash Generated | 5.8 | 1.59 |
| Cash at the Start | 10 | 16 |
| Cash at the End | 15.8 | 17.59 |
Share Holding Pattern
| Name | Designation |
|---|---|
| Hari Prakash Gupta | MD |
| Siddharth Gupta | Joint MD |
| Jai Narayan Tiwari | CFO |
Frequently Asked Questions (FAQ)
Find answers to common questions, providing clarity and insights to address any queries on your mind.
Contact Us: Reach out to Unlistify to confirm availability and agree on a price.
Provide KYC: Submit your Client Master Report, PAN card, and a cancelled cheque.
Make Payment: Transfer funds to our designated bank account (RTGS/NEFT/IMPS/cheque). Ensure the payment originates from the same account where you want the shares credited.
Receive Shares: We’ll transfer the Hicks Thermometers shares to your Demat account within 24 hours of payment confirmation.
Get a Quote: Unlistify will provide a buyback price for your Hicks Thermometers shares.
Share Details: Submit your Client Master Report.
Transfer Shares: Transfer the Hicks Thermometers shares to our Demat account using a DIS (Delivery Instruction Slip).
Receive Payment: We’ll transfer funds to your bank account within 24 hours of receiving the shares (RTGS/NEFT/IMPS/cheque). For security reasons, payment will only be made to the account linked to your Demat
DIS (Delivery Instruction Slip): A DIS is a form used to authorize the transfer of shares from your Demat account.
Methods:
Offline DIS: Fill out a physical DIS form with details like the ISIN number, quantity, price of your Hicks Thermometers shares, and our account information. Submit this to your broker.
Online DIS: Some brokers offer online DIS systems for easier transfers.
Unlistify aims to make unlisted share investing accessible. The current minimum investment for Hicks Thermometers Unlisted Shares is approximately 35,000 – 50,000 INR.
Limited Liquidity: Unlisted shares are not traded on public exchanges, making it potentially harder to find buyers when you want to sell.
Price Volatility: Prices can fluctuate more than listed shares due to less publicly available information.
Regulatory Changes: Regulations for unlisted shares can change, affecting their value and trading.
Company-Specific Risks: Each company has its own risks related to its industry, financials, and management.
No Guarantee of Listing: There’s no assurance that unlisted shares will ever be listed on a public exchange.
Market Leader: Unlistify is one of India’s fastest-growing unlisted share platforms.
Transparency: We provide clear information about each unlisted share, including potential risks.
Security: We prioritize the protection of your financial information.
Customer Support: Our team is dedicated to guiding you through the investment process.
Latest Funding: We consider the valuation from Hicks Thermometers most recent funding round.
Comparable Companies: If there’s no recent funding, we analyze similar listed companies to estimate a fair value.
SEBI’s Influence: SEBI regulations do apply to some aspects of unlisted share trading, such as lock-in periods and transaction charges. However, there are no specific SEBI regulations for becoming an unlisted broker.
We aim for same-day transfer of Hicks Thermometers Unlisted Shares to your Demat account after your payment is confirmed.
Tax Transition: Once your unlisted Hicks Thermometers shares are listed and sold on an exchange, standard listed share tax rules apply.
Holding Period: Your holding period (for determining long-term vs. short-term capital gains tax) starts from the original unlisted purchase date.


